Skip to main content
. 2017 Mar 23;8(30):48875–48888. doi: 10.18632/oncotarget.16511

Figure 3. Promoter methylation status of IRF8 in primary breast cancers.

Figure 3

Representative analysis of IRF8 promoter hypermethylation in (A) primary breast cancer tissues (n = 114) and (B) surgical-margin tissues (n = 12) in breast cancer patients. M, methylated; U, unmethylated.